Kinetics of elimination of methotrexate from the cerebrospinal fluid space of monkeys after ventriculolumbar perfusion
- PMID: 406994
Kinetics of elimination of methotrexate from the cerebrospinal fluid space of monkeys after ventriculolumbar perfusion
Similar articles
-
Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.Cancer Treat Rep. 1977 Jul;61(4):633-41. Cancer Treat Rep. 1977. PMID: 406996 No abstract available.
-
Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion.Cancer Treat Rep. 1977 Jul;61(4):625-31. Cancer Treat Rep. 1977. PMID: 406995 No abstract available.
-
A primate model for study of methotrexate pharmacokinetics in the central nervous system.Cancer Res. 1977 Jul;37(7 Pt 1):1982-5. Cancer Res. 1977. PMID: 405092
-
Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.Lab Anim Sci. 1994 Apr;44(2):148-52. Lab Anim Sci. 1994. PMID: 8028278
-
Intrathecal methotrexate-induced neurotoxicities.Am J Hosp Pharm. 1981 Jan;38(1):65-8. Am J Hosp Pharm. 1981. PMID: 7011005 Review.
Cited by
-
Clinical pharmacokinetics of cerebrospinal fluid.Clin Pharmacokinet. 1982 Jul-Aug;7(4):312-35. doi: 10.2165/00003088-198207040-00003. Clin Pharmacokinet. 1982. PMID: 6749368 Review.